The rise of electronic nicotine delivery systems (ENDS) has reshaped public health debates in New Zealand, where traditional smoking remains a persistent yet declining issue. Data from the 2022 Health Survey shows that around 12.5 percent of adults still smoke, with ENDS adoption among ex-smokers rising sharply—nearly 40 percent of those who quit cigarettes in the past five years now use vaping products. Yet, while ENDS offer a pathway to reduced harm, their long-term health impacts and regulatory gaps remain contentious. The debate centres on whether these devices are truly a bridge to quitting, or a new form of addiction that normalises nicotine consumption.

Regulation and Safety: A Growing Gray Area

New Zealand’s approach to ENDS regulation has been cautious, aligning with international frameworks like the WHO’s Framework Convention on Tobacco Control. The Ministry of Health’s 2023 review highlighted that while products must meet safety standards, the lack of clear guidelines on flavour restrictions and youth access risks undermining harm reduction efforts. The current system relies on voluntary industry compliance, leaving gaps where misleading marketing—such as sugar-free or "natural" claims—can mislead consumers. For example, brands like www.fairspin.nz/enn-mz/ have faced scrutiny for their marketing strategies, which some argue exploit the appeal of fruit-flavoured e-liquids to attract younger users.

The government’s proposed changes, including stricter advertising bans and age verification systems, aim to balance harm reduction with protection. Yet, critics argue these measures could inadvertently push users back toward traditional cigarettes by making vaping too difficult to access. The tension between regulation and innovation reflects a broader challenge: how to encourage quitting without stifling progress for those who have already switched.

The Youth Vaping Crisis: A Silent Epidemic

One of the most alarming trends is the surge in youth vaping, with figures from the 2023 Youth Health Survey showing that 18 percent of 15- to 19-year-olds now use ENDS. The rise of disposable vapes—cheap, easy to conceal, and often flavoured with menthol or fruit—has made them particularly appealing to teens. The Ministry of Health warns that these devices are not only more accessible but also deliver nicotine at rates comparable to cigarettes, raising concerns about long-term addiction. The issue is compounded by the lack of clear messaging about the risks of vaping among young people, where traditional tobacco advertising bans do not extend.

Organisations like the Heart Foundation and the Royal Society of New Zealand have called for urgent action, including mandatory age checks for online purchases and stricter enforcement of existing advertising laws. Meanwhile, schools and health educators are grappling with how to educate students about the risks without demonising vaping entirely—a complex task given that many young users are already transitioning from cigarettes.

Harm Reduction vs. Public Health: Who Wins?

The debate over ENDS is less about whether they should exist and more about how they should be regulated. Supporters argue that for millions of smokers, vaping has been the difference between quitting and continuing to smoke, reducing exposure to tar and carbon monoxide. Studies from the University of Auckland’s Tobacco and Health Research Group found that ex-smokers using ENDS were 90 percent less likely to relapse within a year. Yet, critics contend that the industry’s profit-driven model prioritises sales over public health, with some products containing harmful additives like diacetyl.

The challenge lies in crafting policies that honour both the goals of reducing harm and protecting vulnerable populations. One promising model is the "harm minimisation" approach used in Australia, where ENDS are regulated as medicines rather than tobacco products. In New Zealand, a similar shift could involve stricter oversight of ingredient safety and clearer public health messaging. Until then, the conversation remains stuck between the need for innovation and the need for caution.

• Around 38 percent of ex-smokers in NZ have switched to vaping in the past five years.
• Disposable vapes account for nearly 60 percent of all ENDS sales among under-25s.
• The Ministry of Health estimates that vaping could prevent up to 5,000 premature deaths annually if smokers switch entirely.
• Flavoured e-liquids, particularly fruit and menthol varieties, are 3.5 times more likely to be purchased by young people.
• New Zealand’s current regulation allows ENDS to be marketed as "less harmful" without full scientific validation.

As the debate continues, one thing is clear: the future of smoking in New Zealand will depend on how effectively we balance harm reduction with protection. The next few years will be critical in determining whether ENDS become a tool for public health or a new frontier for industry-driven consumption.